Skip to main content

Posts

Featured

Zimbabwe - access to medicines powered by foreign aid

In September 2017, I was fortunate to visit Zimbabwe as part of the Unitaid NGO delegation. Unitaid, an entity under the World Health Organisation, works on equitable access to quality health technologies worldwide, and it does this by providing grants to organisations with reputable financial track records working on the ground in-country.  On the 13th, I visited a village in Mazowe, about an hours’ drive away from the capital of Harare, to learn from community-based distributors (or CBDAs) of HIV self-testing kits. The kits are the OraQuick tests which works with a sample collected from rubbing one's gums with the diagnostic device provided, and it returns a result within 10 minutes. These test kits, salaries of CBDAs, and tablets to record HIV results, are funded by Unitaid.  In this picture I took in Mazowe (right), you can see a CBDA explaining to a couple how the HIV self-test works. What struck me was how extremely well trained she was, and she managed to convince

Latest posts

MPP Consultation - Accelerating Access to New HIV/HCV Drugs Tuesday, 19 July 2016 - 21st International AIDS Conference, Durban, South Africa

The Disappointment that was the UNGASS on Drugs

Maximalist IP on a false premise: the Trans-Pacific Partnership (TPP) and threat to access to medicines in Malaysia - Submission to the UN Secretary-General High-Level Panel on Access to Medicines

Losing the Myths on the TPPA: a Rebuttal to IDEAS Malaysia on Regulatory Data Protection for Pharmaceuticals

The Illusion of a ‘Golden Balance’: Access to Medicines and the TPP

HIV, PHARMACEUTICALS AND GLOBAL GOVERNANCE: PERSPECTIVES FROM AN INDIVIDUALISED INTERNATIONAL VISITOR LEADERSHIP PROGRAM (IVLP) IN THE UNITED STATES